Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Tenax Therapeutics, Inc. (TENX)

Pharmaceutical Preparations

https://www.tenaxthera.com

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction.

101 GLEN LENNOX DRIVE, SUITE 300
CHAPEL HILL, NC

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/02/1997

Market Cap

14,247,198

Shares Outstanding

300,000

Weighted SO

298,281

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

ALLR --.--%

NRBO --.--%

HILS --.--%

VRAX --.--%

QNRX --.--%

BWV --.--%

PXMD --.--%

REVB --.--%

ZVSA --.--%

Beta

2.1940

Last Div

0.0000

Range

2.77-61.2

Chg

0.1794

Avg Vol

510061

Mkt Cap

14247198

Exch

NASDAQ

Country

US

Phone

919 855 2100

DCF Diff

3.2754

DCF

0.8943

Div Yield

0.0000

P/S

2460.6560

EV Multiple

-0.9938

P/FV

0.9221

Div Yield %

0.0000

P/E

-1.6453

PEG

-0.0173

Payout

0.0000

Current Ratio

6.0981

Quick Ratio

6.0981

Cash Ratio

5.3905

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

47589.8711

CCC

-47589.8711

Gross Margin

-0.1520

Op Margin

-189.4199

Pretax Margin

-859.1377

Net Margin

-859.1377

Eff Tax Rate

0.5723

ROA

-0.4685

ROE

-0.4890

ROCE

-0.1236

NI/EBT

1.0000

EBT/EBIT

4.5356

EBIT/Rev

-189.4199

Debt Ratio

0.0263

D/E

0.0314

LT Debt/Cap

0.0000

Total Debt/Cap

0.0305

Int Coverage

-44.5052

CF/Debt

-41.0770

Equity Multi

1.1961

Rec Turnover

0.0000

Pay Turnover

0.0077

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0005

OCF/Share

-5.8483

FCF/Share

-5.8475

Cash/Share

4.7921

OCF/Sales

-1977.9556

FCF/OCF

0.9999

CF Coverage

-41.0770

ST Coverage

-41.0770

CapEx Coverage

-7148.7909

Div&CapEx Cov

-7148.7909

P/BV

0.9221

P/B

0.9221

P/S

2460.6560

P/E

-1.6453

P/FCF

-1.2442

P/OCF

-0.7146

P/CF

-0.7146

PEG

-0.0173

P/S

2460.6560

EV Multiple

-0.9938

P/FV

0.9221

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 29, 08:30 Tenax Therapeutics Announces Reverse Stock Split GlobeNewswire Inc. Nov 17, 08:30 Tenax Therapeutics Announces Professor Javed Butler, M.D., M.P.H, M.B.A., joins PH-HFpEF Scientific Advisory Board

Revenue Product Segmentation